+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Foods Market Analysis by Route of Administration, by Product, by Application, Sales Channel and by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 146 Pages
  • August 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5651405
The medical foods market size is estimated to be USD 24.5 billion in 2021 and is expected to witness a CAGR of 7.25% during the forecast period 2022-2029. The rising frequency of communicable and non-communicable diseases, and increased effort for dietary management of such disorders are some of the key drivers for the market growth. Additionally, growing geriatric population, which suffers from a variety of chronic and neurogenic conditions such as dementia, stroke, multiple sclerosis, and swallowing difficulties, needs specialised nutritional treatment is projected to drive the market growth in near future. However, the lack of awareness about medical foods are expected to restrain the market growth.

By Route of Administration

Based on route of administration, the market is bifurcated into enteral and oral. In 2021, the oral segment accounted for the highest revenue share due to the rising production of powdered, pilled, and pre-thickened oral goods and the typical practice of administering therapeutic meals via the oral route.

By Product

On the basis of product, the market is segregated into powder, pills, liquid, and others. In 2021, the powder segment accounted for the highest revenue share owing to the growing consumer desire and comfort levels among paediatric and geriatric patients with various chronic conditions are driving the segment's expansion and the widespread commercial availability of powdered medicinal meals.

By Application

Based on application, the market is categorized into depression, chronic kidney disease, chemotherapy-induced diarrhea, ADHD, orphan disease, alzheimer’s disease, nutritional deficiency, pathogen-related infections, dysphagia, wound healing, protein booster, epilepsy, and pain management. In 2021, the chemotherapy-induced diarrhea segment accounted for the highest revenue share due to individuals using a number of cytotoxic medications, including irinotecan and fluoropyrimidines.

By Sales Channel

On the basis of sales channel, the market is segregated into institutional sales, online sales, and retail sales. In 2021, the institutional sales segment accounted for the highest revenue share owing to the rise in the number of patients seeking treatment for various chronic and nutritional diseases at hospitals and other healthcare facilities.

Regional Markets

In 2021, North America region accounted for the highest revenue in the medical foods market and is expected to maintain its dominance during the forecast period. This is attributed to the existence of worldwide firms such as Abbott Laboratories and Mead Johnson & Company, and their significant revenue generation. Furthermore, strategic initiatives by leading players in the form of mergers, acquisitions, and product launches, and increasing rate of chronic diseases and rising adoption of medical food items by healthcare professionals and patients, are fuelling market growth. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to developing healthcare infrastructure, growing number of cancer diabetic patients, and rising healthcare awareness in this region.

Competitor Insights

Some of the key players operating in the medical foods market are Cargill, Incorporated (US), BASF SE (Germany), Archer Daniels Midland Company (US), DuPont (US), Arla Foods (Denmark), Kerry Group (Ireland), Ajinomoto Co., Inc. (Japan), Koninklijke DSM N.V. (Netherlands), Ingredion Incorporated (US), and Tate & Lyle PLC (UK). Some of the other players include Chr. Hansen Holding A/S (Denmark), Kemin Industries, Inc. (US), BENEO (Germany), Royal Cosun (Netherland), Roquette Frères (France), Soylent (US), A&B Ingredients (US), Golden Grain Group Limited (China), Sugarlogix (US), and Stratum Nutrition (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including route of administration, product, application, and sales channel from 2021 to 2029.

Segmentation: Medical Foods Market Report 2021-2029

By Route of Administration (Revenue, USD Billion)

  • Enteral
  • Oral

Product (Revenue, USD Billion)

  • Powder
  • Pills
  • Liquid
  • Others

By Application (Revenue, USD Billion)

  • Depression
  • Chronic Kidney Disease
  • Chemotherapy Induced Diarrhoea
  • ADHD
  • Orphan Disease
  • Alzheimer’s Disease
  • Nutritional Deficiency’
  • Pathogen Related Infections
  • Dysphagia
  • Wound Healing
  • Protein Booster
  • Epilepsy
  • Pain Management

By Sales Channel (Revenue, USD Billion)

  • Institutional Sales
  • Online Sales
  • Retail Sales

By Region (Revenue, USD Billion)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1.Study Objectives
1.2.Study Scope
1.3.Research Assumptions
1.4.Research Framework
1.4.1.Research Models
1.4.1.1.Bottom-up Approach
1.4.1.2.Top-down Approach
1.4.1.3.Data Triangulation
1.4.2.Data Procurement
1.4.2.1.Internal Database
1.4.2.2.Secondary Research
1.4.2.3.Purchased Database
1.4.2.4.Primary Research
1.4.3.Data Analysis
1.4.3.1.Data Validation
1.4.3.2.Market Size Estimation
1.4.3.3.Market Forecast Model
1.4.4.Quality Assessment
2. Introduction: Medical Foods
3. Executive Summary
3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1.Driver 1
4.1.2.Driver 2
4.1.3.Driver 3
4.1.4.Driver 4
4.1.5.Driver 5
4.2.Market Restraint
4.2.1.Restraint 1
4.2.2.Restraint 2
4.2.3.Restraint 3
4.2.4.Restraint 4
4.3.Market Opportunities
4.3.1.Opportunity 1
4.3.2.Opportunity 2
4.3.3.Opportunity 3
4.3.4.Opportunity 4
4.4.Market Trends
4.4.1.Trend 1
4.4.2.Trend 2
4.4.3.Trend 3
4.4.4.Trend 4
4.5.Market Challenges
4.5.1.Challenge 1
4.5.2.Challenge 2
4.5.3.Challenge 3
4.5.4.Challenge 4
5. Market Environment Analysis
5.1.Porter’s 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark
6. COVID-19 Impact Analysis: Medical Foods Market
6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets
7. Market Analysis by Route of Administration
7.1.Enteral
7.1.1.Enteral Market Forecast, 2021-2029 (USD Million)
7.2.Oral
7.2.1.Oral Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Product
8.1.Powder
8.1.1. Powder Market Forecast, 2021-2029 (USD Million)
8.2.Pills
8.2.1.Pills Market Forecast, 2021-2029 (USD Million)
8.3.Liquid
8.3.1.Liquid Market Forecast, 2021-2029 (USD Million)
8.4.Others
8.4.1.Others Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by Application
9.1.Depression
9.1.1. Depression Market Forecast, 2021-2029 (USD Million)
9.2.Chronic Kidney Disease
9.2.1.Chronic Kidney Disease Market Forecast, 2021-2029 (USD Million)
9.3.Chemotherapy Induced Diarrhoea
9.3.1.Chemotherapy Induced Diarrhoea Market Forecast, 2021-2029 (USD Million)
9.4.ADHD
9.4.1.ADHD Market Forecast, 2021-2029 (USD Million)
9.5.Orphan Disease
9.5.1.Orphan Disease Market Forecast, 2021-2029 (USD Million)
9.6.Alzheimer’s Disease
9.6.1.Alzheimer’s Disease Market Forecast, 2021-2029 (USD Million)
9.7.Nutritional Deficiency’
9.7.1.Nutritional Deficiency’ Market Forecast, 2021-2029 (USD Million)
9.8.Pathogen Related Infections
9.8.1.Pathogen Related Infections Market Forecast, 2021-2029 (USD Million)
9.9.Dysphagia
9.9.1.Dysphagia Market Forecast, 2021-2029 (USD Mil
9.10.Wound Healing
9.10.1.Wound Healing Market Forecast, 2021-2029 (USD Million)
9.11.Protein Booster
9.11.1.Protein Booster Market Forecast, 2021-2029 (USD Million)
9.12.Epilepsy
9.12.1.Epilepsy Market Forecast, 2021-2029 (USD Million)
9.13.Pain Management
9.13.1.Pain Management Market Forecast, 2021-2029 (USD Million)
10. Market Analysis by Sales Channel
10.1.Institutional Sales
10.1.1.Institutional Sales Market Forecast, 2021-2029 (USD Million)
10.2.Online Sales
10.2.1.Online Sales Market Forecast, 2021-2029 (USD Million)
10.3.Retail Sales
10.3.1.Retail Sales Market Forecast, 2021-2029 (USD Million)
11. Regional Market Analysis
11.1.Regional Market Trends
11.2.Regional Market: Comparative Analysis
12. North America Medical Foods Market
12.1.North America Medical Foods Market
12.1.1.North America Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.1.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
12.1.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
12.2.U.S. Medical Foods Market
12.2.1.U.S. Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.2.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
12.2.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
12.3.Canada Medical Foods Market
12.3.1.Canada Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
12.3.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
12.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
12.3.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13. Europe Medical Foods Market
13.1.Europe Medical Foods Market
13.1.1.Europe Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.1.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.1.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13.2.Germany Medical Foods Market
13.2.1.Germany Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.2.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.2.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13.3.UK Medical Foods Market
13.3.1.UK Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.3.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.3.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13.4.France Medical Foods Market
13.4.1.France Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.4.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.4.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13.5.Spain Medical Foods Market
13.5.1.Spain Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.5.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.5.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13.6.Italy Medical Foods Market
13.6.1.Italy Market Size and Forecast, 2021-2029 (USD Million)
13.6.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.6.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.6.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.6.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
13.7.Rest of EuropeMedical Foods Market
13.7.1.Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
13.7.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
13.7.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
13.7.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
13.7.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14. Asia PacificMedical Foods Market
14.1.Asia PacificMedical Foods Market
14.1.1.Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.1.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.1.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14.2.Japan Medical Foods Market
14.2.1.Japan Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.2.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.2.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14.3.China Medical Foods Market
14.3.1.China Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.3.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.3.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14.4.India Medical Foods Market
14.4.1.India Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.4.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.4.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14.5.South Korea Medical Foods Market
14.5.1.South Korea Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.5.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.5.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14.6.Australia Medical Foods Market
14.6.1.Australia Market Size and Forecast, 2021-2029 (USD Million)
14.6.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.6.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.6.1.3.Market Size and Forecast by Application 2021-2029 (USD Million)
14.6.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
14.7.Rest of Asia Pacific Medical Foods Market
14.7.1.Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
14.7.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
14.7.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
14.7.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
14.7.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
15. Latin America Medical Foods Market
15.1.Latin America Medical Foods Market
15.1.1.Latin America Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.1.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.1.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
15.2.BrazilMedical Foods Market
15.2.1.Brazil Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.2.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
15.3.MexicoMedical Foods Market
15.3.1.Mexico Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.3.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.3.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
15.4.Argentina Medical Foods Market
15.4.1.Argentina Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.4.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.4.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
15.5.Rest of Latin America Medical Foods Market
15.5.1.Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
15.5.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
15.5.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
15.5.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
15.5.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
16. MEAMedical Foods Market
16.1.MEA Medical Foods Market
16.1.1.MEA Market Size and Forecast, 2021-2029 (USD Million)
16.1.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.1.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.1.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.1.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
16.2.GCC Medical Foods Market
16.2.1.GCC Market Size and Forecast, 2021-2029 (USD Million)
16.2.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.2.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.2.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.2.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
16.3.South Africa Medical Foods Market
16.3.1.South Africa Market Size and Forecast, 2021-2029 (USD Million)
16.3.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.3.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.3.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.3.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
16.4.Rest of MEA Medical Foods Market
16.4.1.Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
16.4.1.1.Market Size and Forecast by Route of Administration, 2021-2029 (USD Million)
16.4.1.2.Market Size and Forecast by Product, 2021-2029 (USD Million)
16.4.1.3.Market Size and Forecast by Application, 2021-2029 (USD Million)
16.4.1.4.Market Size and Forecast by Sales Channel, 2021-2029 (USD Million)
17. Competitor Analysis
17.1.Market Share Analysis, 2021 & 2029
17.2.Competitive Mapping
17.3.Key Players Market Place Analysis
17.4.Major Recent Developments
18. Company Profiles
18.1.Cargill, Incorporated (US)
18.1.1.Company Snapshot
18.1.2.Company Overview
18.1.3.Financials
18.1.4.Product Benchmarking
18.1.5.Recent Developments
18.2.BASF SE (Germany)
18.2.1.Company Snapshot
18.2.2.Company Overview
18.2.3.Financials
18.2.4.Product Benchmarking
18.2.5.Recent Developments
18.3.Archer Daniels Midland Company (US)
18.3.1.Company Snapshot
18.3.2.Company Overview
18.3.3.Financials
18.3.4.Product Benchmarking
18.3.5.Recent Developments
18.4.DuPont (US)
18.4.1.Company Snapshot
18.4.2.Company Overview
18.4.3.Financials
18.4.4.Product Benchmarking
18.4.5.Recent Developments
18.5.Arla Foods (Denmark)
18.5.1.Company Snapshot
18.5.2.Company Overview
18.5.3.Financials
18.5.4.Product Benchmarking
18.5.5.Recent Developments
18.6.Kerry Group (Ireland)
18.6.1.Company Snapshot
18.6.2.Company Overview
18.6.3.Financials
18.6.4.Product Benchmarking
18.6.5.Recent Developments
18.7.Ajinomoto Co., Inc. (Japan)
18.7.1.Company Snapshot
18.7.2.Company Overview
18.7.3.Financials
18.7.4.Product Benchmarking
18.7.5.Recent Developments
18.8.Koninklijke DSM N.V. (Netherlands)
18.8.1.Company Snapshot
18.8.2.Company Overview
18.8.3.Financials
18.8.4.Product Benchmarking
18.8.5.Recent Developments
18.9.Ingredion Incorporated (US)
18.9.1.Company Snapshot
18.9.2.Company Overview
18.9.3.Financials
18.9.4.Product Benchmarking
18.9.5.Recent Developments
18.10.Tate & Lyle PLC (UK)
18.10.1.Company Snapshot
18.10.2.Company Overview
18.10.3.Financials
18.10.4.Product Benchmarking
18.10.5.Recent Developments
18.11. Kemin Industries, Inc. (US)
18.11.1.Company Snapshot
18.11.2.Company Overview
18.11.3.Financials
18.11.4.Product Benchmarking
18.11.5.Recent Developments
18.12.BENEO (Germany)
18.12.1.Company Snapshot
18.12.2.Company Overview
18.12.3.Financials
18.12.4.Product Benchmarking
18.12.5.Recent Developments
18.13.Royal Cosun (Netherland)
18.13.1.Company Snapshot
18.13.2.Company Overview
18.13.3.Financials
18.13.4.Product Benchmarking
18.13.5.Recent Developments
18.14.Roquette Frères (France)
18.14.1.Company Snapshot
18.14.2.Company Overview
18.14.3.Financials
18.14.4.Product Benchmarking
18.14.5.Recent Developments
18.15. Soylent (US)
18.15.1.Company Snapshot
18.15.2.Company Overview
18.15.3.Financials
18.15.4.Product Benchmarking
18.15.5.Recent Developments
18.16.Others Prominent Players
19. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cargill Incorporated (US)
  • BASF SE (Germany)
  • Archer Daniels Midland Company (US)
  • DuPont (US)
  • Arla Foods (Denmark)
  • Kerry Group (Ireland)
  • Ajinomoto Co. Inc. (Japan)
  • Koninklijke DSM N.V. (Netherlands)
  • Ingredion Incorporated (US)
  • Tate & Lyle PLC (UK). Some of the other players include Chr. Hansen Holding A/S (Denmark)
  • Kemin Industries Inc. (US)
  • BENEO (Germany)
  • Royal Cosun (Netherland)
  • Roquette Frères (France)
  • Soylent (US)
  • A&B Ingredients (US)
  • Golden Grain Group Limited (China)
  • Sugarlogix (US)
  • Stratum Nutrition (US).